796-47-4

Basic information

• Product Name: Benzoic acid, 2-[[(2-hydroxy-1-naphthalenyl)methylene]amino]-
• CAS NO: 796-47-4
• Molecular Formula: C18H13NO3
• Molecular Weight: 291.306
• Mol File: 796-47-4.mol

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-[[(2-hydroxy-1-naphthalenyl)methylene]amino]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-[[(2-hydroxy-1-naphthalenyl)methylene]amino]-(796-47-4)
• EPA Substance Registry System: Benzoic acid, 2-[[(2-hydroxy-1-naphthalenyl)methylene]amino]-(796-47-4)

Safety Data

• Hazardous Substances Data: 796-47-4(Hazardous Substances Data)

Upstream product

• 118-92-3 anthranilic acid 
• 708-06-5 2-hydroxynaphthalene-1-carbaldehyde 

Downstream Products

• 344792-35-4 [Cu(N-2-hydroxy-naphthaldehyde-1-alkenyl-o-amino acid-2H)](n) 
• 55003-74-2 Pr⁽³⁺⁾*C₁₈H₁₁NO₃^(2-)*C₁₈H₁₂NO₃^(1-)=Pr(C₁₈H₁₁NO₃)(C₁₈H₁₂NO₃) 
• 55003-72-0 La⁽³⁺⁾*C₁₈H₁₁NO₃^(2-)*C₁₈H₁₂NO₃^(1-)=La(C₁₈H₁₁NO₃)(C₁₈H₁₂NO₃) 
• 55003-76-4 Sm⁽³⁺⁾*C₁₈H₁₁NO₃^(2-)*C₁₈H₁₂NO₃^(1-)=Sm(C₁₈H₁₁NO₃)(C₁₈H₁₂NO₃) 
• 55003-75-3 Nd⁽³⁺⁾*C₁₈H₁₁NO₃^(2-)*C₁₈H₁₂NO₃^(1-)=Nd(C₁₈H₁₁NO₃)(C₁₈H₁₂NO₃) 
• 55003-73-1 Ce⁽³⁺⁾*C₁₈H₁₁NO₃^(2-)*C₁₈H₁₂NO₃^(1-)=Ce(C₁₈H₁₁NO₃)(C₁₈H₁₂NO₃) 

Relevant articles and documents

A turn-on type stimuli-responsive fluorescent dye with specific solvent effect: Implication for a new prototype of paper using water as the ink

In this study, we reported the photoluminescence (PL) behaviour of a new intramolecular charge transfer (ICT) compound, ((E)-2-(((2-hydroxynaphthalen-1-yl)methylene)amino)benzoic acid, (HABA), which shows ICT solvent effect in aprotic solvents as confirme

SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX

Compositions and methods for treating thrombosis, inflammation, and atherosclerosis by administration of a compound that binds to KRIT1 to inhibit binding with HEG1.

Synthesis of Chemically and Configurationally Stable Monofluoro Acylboronates: Effect of Ligand Structure on their Formation, Properties, and Reactivities

The recent disclosures of two classes of acylborons, potassium acyltrifluoroborates (KATs) and N-methyliminodiacetyl (MIDA) acylboronates, demonstrated that certain acylboron species can be both remarkably stable and uniquely reactive. Here we report new classes of ligands for acylboronates that have a significant influence on the formation, properties, and reactivities of acylboronates. Our systematic investigations identified a class of neutral, monofluoroboronates that can be prepared in a one step, gram-scale fashion from readily accessible KATs. These monofluoroboronates are stable to air, moisture, and silica gel chromatography and can be easily handled without any special precautions. X-ray crystallography, NMR spectroscopy, and HPLC studies showed that they are tetravalent, configurationally stable B-chiral acylboronates. Significantly, the ligands on the boronate allow for fine-tuning of the properties and reactivity of acylboronates. In amide-forming ligation with hydroxylamines under aqueous conditions, a considerable difference in reactivity was observed as a function of ligand structure. The solid-state structures suggested that subtle steric and conformational factors modulate the reactivities of the acylboronates.

Sirtuin Inhibiting Compounds

Provided herein are compositions and methods for treating or preventing cancer and autoimmune diseases. Compositions comprise a sirtuin inhibitory compound that decreases the activity of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contact

Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (sirtuin) inhibitors

In a search for potent inhibitors of class III histone/protein deacetylases (sirtuins), a series of sirtinol analogues have been synthesized and the degree of inhibition was assessed in vitro using recombinant yeast Sir2, human SIRT1, and human SIRT2 and in vivo with a yeast phenotypic assay. Two analogues, namely, 3- and 4-[(2-hydroxy-1-naphthalenylmethylene)-amino]-N-(1-phenylethyl) benzamide (i.e., m- and p-sirtinol), were 2- to 10-fold more potent than sirtinol against human SIRT1 and SIRT2 enzymes. In yeast in vivo assay, these two small molecules were as potent as sirtinol. Compounds lacking the 2-hydroxy group at the naphthalene moiety or bearing several modifications at the benzene 2′-position of the aniline portion (carbethoxy, carboxy, and cyano) were 1.3-13 times less potent than sirtinol, whereas the 2′-carboxamido analogue was totally inactive. Both (R)- and (S)-sirtinol had similar inhibitory effects on the yeast and human enzymes, demonstrating no enantioselective inhibitory effect.